Guishuai Lv
- Molecular Biology top 5%
- Cancer Research top 2%
- Oncology top 10%
- Immunology top 10%
- Pulmonary and Respiratory Medicine
- Topics
- MicroRNA in disease regulation (4 papers)interferon and immune responses (3 papers)Cancer Cells and Metastasis (3 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Guishuai Lv
18 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Biology 1.3k
- Cancer Research 1.0k
- Oncology 330
- Immunology 305
- Pulmonary and Respiratory Medicine 180
Countries citing papers authored by Guishuai Lv
This map shows the geographic impact of Guishuai Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guishuai Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guishuai Lv more than expected).
Fields of papers citing papers by Guishuai Lv
This network shows the impact of papers produced by Guishuai Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guishuai Lv. The network helps show where Guishuai Lv may publish in the future.
Co-authorship network of co-authors of Guishuai Lv
This figure shows the co-authorship network connecting the top 25 collaborators of Guishuai Lv. A scholar is included among the top collaborators of Guishuai Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guishuai Lv. Guishuai Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancerbreakdown → | 62 |
| 4 | 31 | |
| 5 | 86 | |
| 6 | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesisbreakdown → | 260 |
| 7 | 179 | |
| 8 | 41 | |
| 9 | 64 | |
| 10 | Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancerbreakdown → | 779 |
| 11 | 40 | |
| 12 | 123 | |
| 13 | 28 | |
| 14 | 36 | |
| 15 | 9 | |
| 16 | 20 | |
| 17 | 179 | |
| 18 | 50 |
About Guishuai Lv
Guishuai Lv is a scholar working on Cancer Research, Nutrition and Dietetics and Immunology, having authored 18 papers that have together received 2.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), interferon and immune responses (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.3k citations) and Immunology (305 citations). Guishuai Lv has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Hongyang Wang, Hongwei Lv, Wen Yang, Tian Fang, Changzheng Wang, Qin Han, Liang Tang, Shanhua Tang, Linna Guo and Le‐Xing Yu. Their work appears in journals such as Nature, Nature Communications and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.